EcoR1 Capital, LLC's Net Worth

$509 Million

Who is EcoR1 Capital, LLC?

EcoR1 Capital, LLC has an estimated net worth of $509 Million. This is based on reported shares across multiple companies, which include Odonate Therapeutics, Inc., Nuvation Bio Inc., PROTHENA CORP PUBLIC LTD CO, Panacea Acquisition Corp. II, Celladon Corp, Voyager Therapeutics, Inc., ANAPTYSBIO, INC, Surface Oncology, Inc., Corvus Pharmaceuticals, Inc., Zymeworks Inc., Akouos, Inc., Mersana Therapeutics, Inc., TScan Therapeutics, Inc., Graphite Bio, Inc., GENVEC INC, and Tango Therapeutics, Inc..

SEC CIK

EcoR1 Capital, LLC's CIK is 0001587114

Past Insider Trading and Trends

2021 was EcoR1 Capital, LLC's most active year for acquiring shares with 45 total transactions. EcoR1 Capital, LLC's most active month to acquire stocks was the month of January. 2021 was EcoR1 Capital, LLC's most active year for disposing of shares, totalling 9 transactions. EcoR1 Capital, LLC's most active month to dispose stocks was the month of November. 2021 saw EcoR1 Capital, LLC paying a total of $154,143,154.93 for 21,174,343 shares, this is the most they've acquired in one year. In 2022 EcoR1 Capital, LLC cashed out on 1,730,973 shares for a total of $45,294,565.03, their largest year based on trade value.